Back to search results

Wearable Devices and Biomarkers Project (Healthiomics) for Brain Cancer and Neurological Disorders

This study, called Healthiomics, is collecting health information and biological samples (like blood, tumor, or urine) from patients with tumors, cancer, or neurological disorders. The goal is to create a collection of these samples and data to help researchers find new ways to predict how diseases will progress, understand how treatments work, and develop personalized treatments. This could lead to better care for patients, especially those with brain tumors. You can join if you are 18 or older and have a scheduled appointment with oncology (cancer care) or neurosciences at a participating medical facility. The study aims to store these specimens and data for at least 4 years.

Study design
This is an observational study, meaning researchers will collect information without giving any specific interventions. It plans to enroll about 3500 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Specimens and data will be stored for at least 4 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05106725

Wearable Devices and Biomarkers Project (Healthiomics)

Recruiting
Not specifiedAges 18+Observational
CureScience
~3,500 participants
Updated 2024-08-21 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Specimen and data storage
Measured over 4 years

Conditions

Brain Cancer
Neurological Disorder
Neurological Cancer

Explore related trials

Malignant Brain NeoplasmNervous System Disorder

Where it's being run

1 sites across 1 states
California1

Study leadership

  • Feng Lin, MD PhD · PRINCIPAL_INVESTIGATOR · CureScience

Who to contact

Amanda Wilburn
[email protected]
8588002873
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Participant or participant's legally authorized representative has the ability to understand and the willingness to provide a signed and dated informed consent form.
Participant is ≥ 18 years of age.
Participant had/has a scheduled appointment with oncology or neurosciences services at the participating medical and surgical facility.
Participant is characterized by at least one of the following criteria:

Exclusion

Participant or participant's legally authorized representative is unable to provide informed consent.

What this trial measures

  • Specimen and data storage4 years

    To collect and store biological specimens (such as, but not limited to, tissue, blood, urine, cerebrospinal fluid, etc.), data from functional and anatomical imaging modalities, digital health data and clinical data from patients with cancer or neurological disorders, those who are under evaluation for a possible cancer or neurologic disorders, or healthy controls.